Drug Markets/Tapinarof

Tapinarof

1 NDC across 1 manufacturer|0 Generic,1 Brand

Tapinarof is used to treat psoriasis, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on May 23, 2022. In 2024, Medicare Part D spent $27 million on Tapinarof across 19,000 claims for 8,600 beneficiaries.

Tapinarof is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $25.23 to $25.23 per GM. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

1

0G / 1B

Manufacturers

1

competing in market

Price Spread

$25.23 – $25.23

per GM

7d Activity

1↓0 flat

avg -0.1% WoW · of 1 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing TAPINAROF

Drug Portfolio

1 NDCs total, 1 shown

Drug ↕Price 7d Change ↕
VTAMA 1% CREAM
$25.2305
per GM
-0.07%

Frequently Asked Questions

What is Tapinarof used to treat?

Tapinarof is used to treat psoriasis, per the National Library of Medicine's MED-RT classification.

How much does Medicare spend on Tapinarof?

In 2024, Medicare Part D spent $27 million on Tapinarof across 19,000 claims for 8,600 beneficiaries.

How many Tapinarof products are on the market?

The Tapinarof drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.

What is the price range for Tapinarof?

NADAC reference prices for Tapinarof range from $25.2305 to $25.2305 per GM.

Which manufacturers make Tapinarof?

1 manufacturer lists Tapinarof in NADAC. Ranked by number of NDCs, the largest are Organon LLC (1).

How has the price of Tapinarof changed recently?

Over the past 7 days, 0 Tapinarof NDCs rose and 1 fell, with a market-wide average change of -0.1%.